EUVIMEDEUVIMED entdecken
MetaanalyseVergleichsstudie

Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin

Samer Al Said iD, Eugene Braunwald, Michael G Palazzolo iD, Giorgio E M Melloni iD, Bram J Geller iD, Christian T Ruff iD, Elliott M Antman, Anthony P Carnicelli iD, John W Eikelboom iD, Christopher B Granger iD, Manesh R Patel iD, Lars Wallentin iD und 1 weitere

Circulation · 24.02.2026 · 153 (8) · 567-575

DOI: 10.1161/circulationaha.125.075275 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Circulation, erschienen am 24.02.2026. Verfasst von Samer Al Said und 12 weiteren Autor:innen. Beteiligte Einrichtung: Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical …. Hauptthemen laut MEDLINE: Atrial Fibrillation, Warfarin, Anticoagulants, Embolism. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Systemic embolic events (SEEs) are a serious but underrecognized complication of atrial fibrillation. Although non–vitamin K antagonist oral anticoagulants prevent ischemic stroke (IS), their efficacy in SEE and the clinical characteristics of patients who experience SEE remain poorly understood. METHODS: We analyzed individual patient data from 4 pivotal randomized trials enrolling patients between 2005 and 2010 comparing non–vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation. We characterized the incidence, clinical features, management, and outcomes of clinically overt SEE and compared results in these patients with patients who had an IS. RESULTS: Among 71 683 patients, 188 experienced SEE (26 with concurrent IS), yielding an annualized event rate of 0.13% per patient-year, compared with 1.25% per patient-year for IS (n=1797). Among 171 patients with SEE as their first event, median age was 75 years (interquartile range, 68–80), 49.7% were female, and mean±SD CHA 2 DS 2 -VASc score was 4. 7 ±1.5. Compared with IS, patients with SEE had higher rates of peripheral arterial disease (PAD, 16.5% versus 5.4%; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationWarfarinAnticoagulantsEmbolismHumansAgedFemaleMaleAged, 80 and overRandomized Controlled Trials as TopicRisk FactorsAdministration, OralTreatment OutcomeIncidence

Stichwörter der Autor:innen

NOACsatrial fibrillationsystemic embolic eventswarfarin

Substanzen

WarfarinAnticoagulants

Autor:innen und Institutionen

  • Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (S.A.S., E.B., M.G.P., G.E.M.M., C.T.R., E.M.A., R.…
  • Division of Cardiovascular Medicine, Maine Medical Center, Portland (B.J.G.).
  • Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston (A.P.C.).
  • Department of Medicine, McMaster University, Hamilton, Canada (J.W.E.).
  • Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G., M.R.P).
  • Department of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University, Sweden (L.W.).

ORCID-Profile: Samer Al Said, Michael G Palazzolo, Giorgio E M Melloni, Bram J Geller, Christian T Ruff, Anthony P Carnicelli, John W Eikelboom, Christopher B Granger, Manesh R Patel, Lars Wallentin, Robert P Giugliano

Zitieren

APA

Al Said, S., Braunwald, E., Palazzolo, M. G., Melloni, G. E. M., Geller, B. J., Ruff, C. T., Antman, E. M., Carnicelli, A. P., Eikelboom, J. W., Granger, C. B., Patel, M. R., Wallentin, L., & Giugliano, R. P. (2026). Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin. Circulation, 153(8), 567-575. https://doi.org/10.1161/circulationaha.125.075275

Vancouver

Al Said S, Braunwald E, Palazzolo MG, Melloni GEM, Geller BJ, Ruff CT, et al. Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin. Circulation. 2026;153(8):567-575. doi:10.1161/circulationaha.125.075275

BibTeX
@article{AlSaid2026,
  author = {Al Said, Samer and Braunwald, Eugene and Palazzolo, Michael G and Melloni, Giorgio E M and Geller, Bram J and Ruff, Christian T and Antman, Elliott M and Carnicelli, Anthony P and Eikelboom, John W and Granger, Christopher B and Patel, Manesh R and Wallentin, Lars and Giugliano, Robert P},
  title = {Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin},
  journal = {Circulation},
  year = {2026},
  volume = {153},
  number = {8},
  pages = {567--575},
  doi = {10.1161/circulationaha.125.075275}
}
Kostenlos starten →